Get the Stockscreener App
0.9823
5.65%
-0.0577
Renovaro Biosciences Inc Stock (RENB) Forecast
The Renovaro Biosciences Inc (RENB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.2353, representing a +127.56% increase from the current price of $0.9823. The highest analyst price target is $3.6369, and the lowest is $0.8337.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RENB Price Target
Average 2.0701
(+110.74% Upside)
Is Renovaro Biosciences Inc (RENB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 18.54 | Buy |
| STOCH(9,6) | 8.8321 | Buy |
| STOCHRSI(14) | 15.69 | Buy |
| MACD(12,26) | -0.366 | Sell |
| ADX(14) | 36.94 | Sell |
| William %R | -95.83 | Buy |
| CCI(14) | -148.60 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.29
Sell
|
1.2656
Sell
|
| MA20 |
1.5675
Sell
|
1.5485
Sell
|
| MA50 |
2.3242
Sell
|
2.1117
Sell
|
| MA100 |
2.9058
Sell
|
2.5597
Sell
|
| MA200 |
2.7173
Sell
|
0.00
Buy
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, RENB could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 12 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on RENB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 18.54 indicates that RENB is oversold. This indicates that RENB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 8.8321 indicates that RENB is oversold. This indicates that RENB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.69 indicates that RENB is oversold. This suggests that RENB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 36.94 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -148.6 indicates that RENB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RENB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Renovaro Biosciences Inc financial reports and earnings history, Renovaro Biosciences Inc (RENB) stock could reach $7.4042 by 2030, $24.38 by 2040 and $39.64 by 2050. See the projected annual prices until 2050 of the Renovaro Biosciences Inc stock below:
- Renovaro Biosciences Inc (RENB) is expected to reach an average price of $22.75 in 2035, with a high prediction of $22.71 and a low estimate of $10.00. This indicates an $2,216% rise from the last recorded price of $0.9823.
- Renovaro Biosciences Inc (RENB) stock is projected to chart a bullish course in 2040, with an average price target of $22.08, representing an $2,148% surge from its current level. The forecast ranges from a conservative $22.83 to a sky-high $24.38.
- Our analysts predict Renovaro Biosciences Inc (RENB) to jump 4,458% by 2045, soaring from $20.64 to an average price of $44.78, potentially reaching $45.20. While $20.64 is the low estimate, the potential upside is significant.
- Renovaro Biosciences Inc (RENB) stock is expected to climb by 2050, reaching an average of $36.68, a $3,634% jump from its current level. However, a wide range of estimates exists, with high and low targets of $39.64 and $37.10, respectively, highlighting the market's uncertainty.
Renovaro Biosciences Inc Stock (RENB) Year by Year Forecast
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2024
Our forecast for RENB stock price in 2024 now indicates an average price target of $2.874 with a high forecast of $5.25 and a low forecast of $0.498. The average prediction reflects an increase of +192.58% from the last recorded price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.1437 | $0.8337 | $3.6369 | +16.43% |
| July, 2024 | $1.8806 | $1.0938 | $2.0138 | +91.45% |
| August, 2024 | $2.1841 | $1.6874 | $2.5041 | +122.35% |
| September, 2024 | $3.1676 | $1.5109 | $3.2676 | +222.47% |
| October, 2024 | $2.2746 | $2.2546 | $4.0344 | +131.55% |
| November, 2024 | $1.2581 | $0.498 | $2.4729 | +28.07% |
| December, 2024 | $1.6916 | $1.1715 | $2.3515 | +72.21% |
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2025
Renovaro Biosciences Inc Stock (RENB) is expected to reach an average price of $1.4623 in 2025, with a high prediction of $2.8188 and a low estimate of $0.1058. This indicates an +48.87% rise from the last recorded price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.7385 | $0.3985 | $2.115 | -24.82% |
| February, 2025 | $0.5335 | $0.5132 | $0.7919 | -45.69% |
| March, 2025 | $0.1794 | $0.3203 | $2.0238 | -81.74% |
| April, 2025 | $0.0256 | $0.2001 | $0.5176 | -97.39% |
| May, 2025 | $0.7315 | $0.1058 | $0.8715 | -25.54% |
| June, 2025 | $1.1085 | $0.2018 | $1.5085 | +12.85% |
| July, 2025 | $2.0523 | $1.1553 | $2.8188 | +108.93% |
| August, 2025 | $0.4294 | $0.1665 | $2.1591 | -56.29% |
| September, 2025 | $1.2665 | $0.1262 | $1.3229 | +28.93% |
| October, 2025 | $0.1997 | $0.2035 | $1.2132 | -79.67% |
| November, 2025 | $2.1099 | $0.1862 | $1.95 | +114.79% |
| December, 2025 | $1.7691 | $0.7593 | $1.0597 | +80.10% |
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2026
The predicted value for Renovaro Biosciences Inc (RENB) in 2026 is set at an average of $1.8582. Estimates vary from a peak of $3.68 to a trough of $0.0363, indicating an +89.17% surge from the present price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.5485 | $1.7487 | $1.7788 | +57.64% |
| February, 2026 | $0.898 | $1.008 | $0.9684 | -8.59% |
| March, 2026 | $0.7574 | $0.7877 | $0.5078 | -22.90% |
| April, 2026 | $0.7934 | $0.1071 | $1.6032 | -19.23% |
| May, 2026 | $1.2761 | $0.0363 | $1.0137 | +29.90% |
| June, 2026 | $0.1545 | $0.2155 | $0.6558 | -84.27% |
| July, 2026 | $0.4947 | $0.1753 | $0.2947 | -49.63% |
| August, 2026 | $3.72 | $1.0043 | $3.68 | +278.70% |
| September, 2026 | $1.7524 | $2.3724 | $2.9865 | +78.39% |
| October, 2026 | $2.8682 | $3.2682 | $3.3218 | +191.99% |
| November, 2026 | $2.3741 | $2.5907 | $2.4747 | +141.69% |
| December, 2026 | $2.0665 | $2.13 | $2.2106 | +110.37% |
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Renovaro Biosciences Inc (RENB) is $2.9417, with a high forecast of $5.41 and a low forecast of $0.4733. This indicates an +199.47% increase from the last price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2124 | $0.6324 | $1.063 | -78.38% |
| February, 2027 | $2.2183 | $0.4733 | $0.8933 | +125.82% |
| March, 2027 | $0.8506 | $1.2206 | $2.0747 | -13.40% |
| April, 2027 | $1.2865 | $1.15 | $0.7036 | +30.97% |
| May, 2027 | $1.6177 | $1.573 | $1.6624 | +64.68% |
| June, 2027 | $3.5824 | $4.1224 | $5.41 | +264.69% |
| July, 2027 | $4.8747 | $3.9854 | $4.8647 | +396.26% |
| August, 2027 | $3.9171 | $4.4541 | $4.3178 | +298.77% |
| September, 2027 | $3.4125 | $3.4625 | $3.6133 | +247.40% |
| October, 2027 | $1.4249 | $2.3049 | $3.1156 | +45.06% |
| November, 2027 | $2.3072 | $1.6422 | $1.4042 | +134.88% |
| December, 2027 | $2.0127 | $2.9427 | $3.1734 | +104.90% |
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2028
In 2028, Renovaro Biosciences Inc (RENB) is projected to reach an average price of $5.4775, with a high projection of $8.87 and a low estimate of $2.0851. This indicates an +457.62% rise from the last price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9151 | $2.0851 | $1.7458 | +94.96% |
| February, 2028 | $2.6274 | $2.2981 | $2.3674 | +167.48% |
| March, 2028 | $5.4891 | $2.6405 | $7.14 | +458.80% |
| April, 2028 | $6.688 | $5.5985 | $6.228 | +580.85% |
| May, 2028 | $5.3665 | $5.9035 | $6.4077 | +446.32% |
| June, 2028 | $4.5953 | $4.8553 | $5.0159 | +367.81% |
| July, 2028 | $3.1442 | $3.8942 | $4.4247 | +220.08% |
| August, 2028 | $3.4527 | $2.811 | $2.5939 | +251.49% |
| September, 2028 | $4.0015 | $4.0815 | $4.2721 | +307.36% |
| October, 2028 | $3.1004 | $3.1207 | $2.7912 | +215.62% |
| November, 2028 | $3.4689 | $3.0201 | $3.2089 | +253.14% |
| December, 2028 | $7.8827 | $3.4586 | $8.87 | +702.47% |
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2029
The 2029 price forecast for Renovaro Biosciences Inc Stock (RENB) is $7.2775 on average, with a high prediction of $10.60 and a low estimate of $3.9551. This represents an +640.87% increase from the previous price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.2543 | $7.2116 | $7.7943 | +740.30% |
| February, 2029 | $7.3896 | $7.5641 | $7.9506 | +652.27% |
| March, 2029 | $6.1649 | $6.5448 | $6.7659 | +527.60% |
| April, 2029 | $5.3202 | $6.0102 | $5.7339 | +441.61% |
| May, 2029 | $3.7918 | $3.9798 | $4.3065 | +286.01% |
| June, 2029 | $4.9471 | $4.6181 | $5.3708 | +403.63% |
| July, 2029 | $3.6424 | $4.1024 | $4.8634 | +270.81% |
| August, 2029 | $4.5241 | $3.9551 | $3.8541 | +360.56% |
| September, 2029 | $10.64 | $4.2767 | $10.60 | +983.47% |
| October, 2029 | $9.7177 | $8.8247 | $9.4759 | +889.28% |
| November, 2029 | $9.0294 | $9.3465 | $9.4936 | +819.21% |
| December, 2029 | $7.9112 | $8.0212 | $8.3324 | +705.38% |
Renovaro Biosciences Inc Stock (RENB) Price Forecast for 2030
Renovaro Biosciences Inc Stock (RENB) is expected to reach an average price of $8.61 in 2030, with a high forecast of $12.33 and a low forecast of $4.8901. This signifies an +776.52% surge from the last price of $0.9823.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.6059 | $7.2959 | $7.4042 | +572.50% |
| February, 2030 | $5.1677 | $5.3377 | $5.5689 | +426.08% |
| March, 2030 | $6.7695 | $5.1487 | $6.4695 | +589.15% |
| April, 2030 | $4.8713 | $5.2413 | $5.9154 | +395.90% |
| May, 2030 | $4.936 | $4.8901 | $4.6142 | +402.49% |
| June, 2030 | $12.37 | $5.0948 | $12.33 | +1,159% |
| July, 2030 | $9.8178 | $10.44 | $11.52 | +899.47% |
| August, 2030 | $10.47 | $10.87 | $11.04 | +965.46% |
| September, 2030 | $9.5043 | $9.7209 | $9.9556 | +867.56% |
| October, 2030 | $8.6121 | $8.7925 | $9.2239 | +776.73% |
| November, 2030 | $6.2904 | $6.7104 | $7.4917 | +540.37% |
| December, 2030 | $7.8286 | $6.3175 | $6.5036 | +696.97% |
1.36%
0.05%
Cap:
|
Volume (24h):